Hi Eric
After reading that post again the following quote bodes well for Laninamivir:
"THERE IS AN URGENT NEED TO EXPAND THE AVAILABLE RANGE OF ANTIVIRAL DRUGS THAT CAN BE USED FOR PROPHYLAXIS OR TREATMENT OF INFLUENZA. "
Given Phase III success in Japan there seems to be a chance that the US regulators may provide some sort of acceleration given the current emergency setting. The Japanese trial was quite robust and more to come later this year.
Relenza is good. Lani is better.
- Forums
- ASX - By Stock
- BTA
- the white house speaks !
the white house speaks !, page-13
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online